drugset / Trial / NCT00781157

Phenylephrine for Spinal Induced Hypotension

NCT00781157

Phase 4 Completed 66 enrolled IWK Health Centre
NaSingle-groupQuadruple-blindTreatment

Summary

This study is designed to determine the ED90 for a single dose of phenylephrine for the treatment of spinal induced hypotension in parturients presenting for an elective CD. The ED90 is the effective dose at which 90% of subjects will have a "positive" response to phenylephrine. The primary outcome measure is the ED90 for bolus phenylephrine. Secondary outcomes include the need for additional vasopressors, glycopyrolate to treat bradycardia, and the presence of hypertension following administration of phenylephrine.

Timeline

Start
2008-01
Primary completion
2008-08
Completion
2008-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Phenylephrine Small molecule 100 ug

Indications